We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research links chemoresponse assays, improved ovarian cancer survival rates.
- Abstract
The article focuses on the study which reveals that women diagnosed with ovarian cancer who undergo cancer tumor testing has improved survival rates. It says Richard G. Moore, gynecologic oncologist with the Program in Women's Oncology at Women & Infants Hospital of Rhode Island, was part of the research team. It states that women with recurrent ovarian cancer can benefit from undergoing biopsy and chemosensitivity testing. It mentions the use of ChemoFx® from Precision Therapeutics Inc.
- Subjects
OVARIAN cancer patients; TUMOR diagnosis; MOORE, Richard D.; WOMEN &; Infants Hospital (Providence, R.I.); BIOPSY; HELOMICS Corp.
- Publication
Rhode Island Medical Journal, 2013, Vol 96, Issue 5, p67
- ISSN
0363-7913
- Publication type
Article